Evidence map›Paper›PMID 32606153›Full record

ArticleIn vivo (Athens, Greece)

Protective Effects of

Panagoula Pavlou, Ioanna Antoniadou, Asimina Peraki, Andreas Vitsos, Paraskevas Dallas, Dimitrios Mostratos, Georgios Deliconstantinos, Georgios Papaioannou, Sergei A Grando, Michail Rallis

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Molecular medicine reports · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Panagoula PavlouNational and Kapodistrian University of Athens, School of Health Sciences, Department of Pharmacy, Athens, Greece.
Ioanna AntoniadouNational and Kapodistrian University of Athens, School of Health Sciences, Department of Pharmacy, Athens, Greece.
Asimina PerakiNational and Kapodistrian University of Athens, School of Health Sciences, Department of Pharmacy, Athens, Greece.
Andreas VitsosNational and Kapodistrian University of Athens, School of Health Sciences, Department of Pharmacy, Athens, Greece.
Paraskevas DallasNational and Kapodistrian University of Athens, School of Health Sciences, Department of Pharmacy, Athens, Greece.
Dimitrios MostratosNational and Kapodistrian University of Athens, School of Health Sciences, Department of Pharmacy, Athens, Greece.
Georgios DeliconstantinosNational and Kapodistrian University of Athens, School of Medicine, Department of Experimental Physiology, Athens, Greece.
Georgios PapaioannouNational and Kapodistrian University of Athens, School of Health Sciences, Department of Pharmacy, Athens, Greece.
Sergei A GrandoUniversity of California, Health Gottschalk Medical Plaza, Institute for Immunology, Irvine, CA, U.S.A.
Michail RallisNational and Kapodistrian University of Athens, School of Health Sciences, Department of Pharmacy, Athens, Greece rallis@pharm.uoa.gr.
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimCigarette smoke (CS) is a major environmental health threat. The oxidative stress induced by CS on keratinocytes and the possible protective effect of nicotine, its receptor inhibitors, and Pinus halepensis bark extract in relation to known antioxidants were investigated. MATERIALS AND

methodsPrimary mouse keratinocytes were exposed to cigarette smoke in the presence and absence of Pinus halepensis bark extract (1 μg/ml), rutin (50 μM) and ascorbic acid (250 μM), nicotine (1 μM) with or without mecamylamine (5 μM) and α-bungarotoxin (0.1 μM). Keratinocyte viability and oxidative stress were evaluated by MTT and fluorescence assays.

resultsPinus halepensis bark extract decreased the oxidative stress and increased the viability of keratinocytes, and moreover, these effects were more pronounced compared to the mixture of rutin and L-ascorbic acid. Nicotine significantly enhanced the viability potentiation of the beneficial effect induced by Pinus halepensis bark extract. Mecamylamine and α-bungarotoxin showed no specific effect.

conclusionPinus halepensis bark extract in combination with nicotine may successfully reverse skin damage induced by cigarette smoke.

Indexed as

PinusAnimalsKeratinocytesMiceNicotineOxidative StressPlant BarkPlant ExtractsSmokingNicotinePlant Extractscigarette smokekeratinocytesnicotineOxidative stressPinus halepensis bark extract

Identifiers

PMID32606153
PMCPMC7439855
OpenAlexW3038913248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.